Retatrutide
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
- Purity:
- ≥99% HPLC
- Sizes available:
- 10 mg
Destination: Argentina
PeptoClinic supplies research peptides to Argentina. Material leaves the Argentine operation and ships within the country, and every lot arrives with the report of the independent laboratory that analysed it.
Nothing listed here is an approved medicine, a supplement or a food, and none of it is sold off the shelf. Every order goes through an intake that a physician reviews individually, and what he decides is what determines whether an order proceeds at all. If you are looking for something you can simply add to a cart, this is not it, and that belongs in the first paragraph rather than in a footnote.
The gap between a supplier who says «99% pure» and one who shows it is a document with a letterhead on it. Each lot travels with the certificate of analysis from the laboratory that measured it: task number, date, method and the figure it found. The reports already published are open on this site, uncropped, exactly as the laboratory printed them.
Because there is no single one. What a compound costs for an Argentine destination depends on quantity, vial size, the documentation the programme needs and the dispatch route, and a number dropped into a grid is a number that will be wrong for almost everyone reading it. Describe what you need and a written quote comes back, normally within one business day. The consultation is free and carries no obligation.
Dispatch leaves the Argentine operation in an insulated box with phase-change coolant, tracked, with the contents documented as laboratory reference material. Shipping within the country means no customs step, which is where a held box becomes a ruined lot. For destinations outside Argentina we prepare the research-use declarations and safety sheets, and review them with you before anything moves.
These are the compounds where a document can be shown rather than a claim asserted. The rest of the catalogue is quoted the same way and ships with the certificate belonging to its own lot.
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
Copper-binding tripeptide studied in extracellular matrix and dermal research models.
BPC-157 and TB-500 in a single vial — the pairing most studied together in tissue-repair research.
Modified GRF(1-29) tetrasubstituted analogue without drug affinity complex.
Yes. Argentina is a destination we supply, and from the local operation: dispatch is within the country and is quoted after a technical supply consultation.
No prices are published. Each compound is quoted in writing after a free technical consultation, normally within one business day, because the cost turns on quantity, vial size, documentation and route.
By reading the lot's certificate of analysis rather than the supplier's website. The certificate names the laboratory that took the measurement, the date, the task number and the purity found by HPLC. Full reports are published uncropped, and two of them can be verified directly on the laboratory's own site.
You do not bring one. What releases an order is the physician's review of your consultation, and that review is part of the consultation itself — PeptoClinic does not ask for a prescription from elsewhere and cannot accept one in its place.
The standard held is ≥99% by HPLC. The lowest figure published in a report is 99.669%, on MOTS-c. The floor is shown rather than the best result, because a headline built on the best lot breaks with the next one.
Janoshik Analytical, an independent laboratory that is not paid to reach a result. Reports are published with their letterhead and task number, so what you read is the laboratory's document rather than our summary of it.
In a discreet insulated box with phase-change coolant, tracked. The peptide travels lyophilised, as a powder, which is the form that tolerates transit; reconstitution happens in the destination laboratory.
Tell us the compound, the quantity and the documentation your programme needs. The answer comes back in writing.